Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application?
Our data suggest that PDD significantly cut costs related to recurring UCB. Further studies are needed from an economic point of view.
Our results indicate that EGR-2 is not required to mount normal acute in vivo immune responses against foreign antigens, and suggest instead that it may serve to regulate the response to chronic antigenic exposure, such as that which occurs to autoantigens.